Delivery Order SPE2DX15D3108-SPE2DX24F26CB
Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of repaglinide 1 mg tablets. The $2,763.86 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- The federal contract award is for the delivery of 100 tablets of the pharmaceutical drug Repaglinide 1 mg. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,609.80 and a period of performance through February 5, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,314.56 to supply Repaglinide 1 mg tablets (90-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded without set-aside designation on December 1, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.32 to AmerisourceBergen Drug Corp for the supply of Repaglinide 1 mg tablets (90-count units) under a firm fixed price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement with no small...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,200 to Amerisourcebergen Drug Corporation for the supply of 100 units of 0.5 mg Repaglinide tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The single day order from August 7-8, 2023 is being fulfilled under an existing indefinite-delivery/indefinite-quantity contract vehicle with the DLA, though further details regarding the base IDIQ are not provided....
- This federal contract award, issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, provides pharmaceutical and medical supply products to support military treatment facilities and programs. The contract is a single-award Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. Firm fixed price task orders placed under this IDC...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,810.23, is a firm fixed-price delivery order for the supply of pioglitazone HCL 30 mg tablets. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,023.68 firm fixed price delivery order covers the supply of 4,557,680,329 units of the medication Nateglinide 60 mg Tablet, with a completion date of June 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a...